glp-1 medicamentos y GIP: Las hormonas que están revolucionando el control del peso y la diabetes GLP-1: Mitos, ciencia y realidad.

Age- and diet-specific effects of chronic exposure to Chlorpyrifos on hormones, inflammation and gut microbiota in rats

Semaglutide is a glucagon-like peptide-1 (GLP-1) agonist, which means it mimics the hormone glucagon-like peptide 1 in the body

A second Lys to Arg substitution at position 34 eliminates a potential competing acylation site, ensuring homogeneous conjugation exclusively at Lys26 and simplifying downstream purification

The STEP-1 trial is considered the pivotal trial that demonstrated 14.9% weight loss at 68 weeks with semaglutide 2.4 mg [142]

Turns out they are very important

Why it matters: REDEFINE 3 will be key for regulatory and clinical adoption of CagriSema